By Business/Source
Currency:USD
2025/Q3
Stock NameRevenueRatio
Thrombectomy236.42M66.66%
Embolization and Access118.26M33.34%
By Country/Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States902.07M75.51%
International292.55M24.49%